HIV Health and Wellness

US: President Tried To Let Health Care Providers Refuse To Provide Transgender Care And Abortions — Now He’s Getting Sued

Health care groups are suing the Trump administration arguing that the rule could create a “chilling effect” that would greatly decrease access to abortion and sex reassignment care.

US: LGBT+ advocates sue U.S. government over healthcare 'conscience rule'

LGBT+ advocates filed a lawsuit on Tuesday to block a rule the U.S. government said will allow medical professionals to act according their consciences, but that critics said could deny care to those in need.

US: ACLU Responds to Proposed Changes to Health Care Rights Law

The Department of Health and Human Services proposed a change to the Health Care Rights Law, Section 1557 of the Affordable Care Act, today in an attempt to roll back non-discrimination protections for transgender and nonbinary people, as well as all women and other communities historically marginalized in health care.

Joint Statement on ICD-11 process for trans & gender diverse people

After moving trans-related categories out of the Chapter on Mental Health, the next steps in the process include getting rid of the remaining pathologizing language and advancing towards legal depathologization and universal health coverage.

US: Administration Proposes Rule To Reverse Protections For Transgender Patients

The federal Department of Health and Human Services is proposing to roll back an Obama-era policy intended to protect transgender people from discrimination in health care.

Polish towns go 'LGBT free' ahead of bitter European election campaign

Teresa Drzewiecka grew up during World War Two, when German and Soviet troops battled for control of her town of Swidnik in eastern Poland. Now 83, she sees another threat to her country’s survival: lesbian, gay, bisexual and transgender (LGBT) people.

US: Gilead CEO insists federal government patent for HIV prevention pill Truvada is invalid

The chief executive of Gilead Sciences, the nation’s leading manufacturer of HIV drugs, defended the high cost of a key drug that prevents the lethal infection, telling a House committee Thursday that its hefty profits pay for continued research.

US: Gilead is accused of cutting anti-competitive deals to extend profit on HIV drug combinations

Combination drug “cocktails” to treat HIV infection are an important part of patients’ routine, allowing them to reduce the number of pills they must take each day. But the lifesaving tablets also were the focus of anti-competitive schemes by the nation’s leading HIV drug manufacturer, Gilead Sciences, according to a consumer lawsuit filed Tuesday.